Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04520594

OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Children's Hospital of Eastern Ontario · Academic / Other
Sex
All
Age
5 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine if a plant-based resistant starch that is optimized for the individual will target the underlying cause of inflammatory bowel disease and restore a "healthier" gut microbiome in pediatric participants with inflammatory bowel disease.

Conditions

Interventions

TypeNameDescription
OTHERResistant Starch7.5 g resistant starch/m2 oral consumption
OTHERPlaceboPlacebo oral consumption of food-grade cornstarch

Timeline

Start date
2021-03-03
Primary completion
2024-11-05
Completion
2026-12-31
First posted
2020-08-20
Last updated
2026-01-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04520594. Inclusion in this directory is not an endorsement.

OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial (NCT04520594) · Clinical Trials Directory